EcoDrugPlus

Trace Amine-Associated Receptor 1

Ensembl ID : ENSLCRG00005021064
Gene Symbol: LOC109140422
2 Cross references
379 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSLCRG00005009881
Gene Symbol: LOC113746897
2 Cross references
392 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSLCRG00005009873
Gene Symbol: LOC109142652
2 Cross references
392 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSLCRG00005021062
Gene Symbol: LOC109140566
2 Cross references
433 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSLCRG00005009875
Gene Symbol: LOC109142651
2 Cross references
392 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSLCRG00005009869
Gene Symbol: LOC113746892
2 Cross references
392 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSLCRG00005009535
Gene Symbol: TGFBR1B
3 Cross references
204 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSLCRG00005007156
Gene Symbol: TRPA1B
3 Cross references
200 Possible Orthologues:

Transmembrane P24 Trafficking Protein 3

Ensembl ID : ENSLCRG00005009238
Gene Symbol: LOC104937776
3 Cross references
186 Possible Orthologues:

Transthyretin (Prealbumin, Amyloidosis Type I)

Ensembl ID : ENSLCRG00005015784
Gene Symbol: TTR
3 Cross references
178 Possible Orthologues:

Tryptophan 5-Hydroxylase 1

Ensembl ID : ENSLCRG00005022385
Gene Symbol: LOC104921438
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSLCRG00005005723
Gene Symbol: TPH1A
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).